​

Kymera Therapeutics Ownership | Who Owns Kymera Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Kymera Therapeutics Ownership Summary

Kymera Therapeutics is owned by 99.94% institutional investors, 2.12% insiders. Fmr is the largest institutional shareholder, holding 12.66% of KYMR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.55% of its assets in Kymera Therapeutics shares.

KYMR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKymera Therapeutics99.94%2.12%-2.06%
SectorHealthcare Stocks 244.37%12.11%-156.48%
IndustryBiotech Stocks 379.01%11.75%-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr12.35M12.66%$1.42B
Baker bros. advisors lp8.66M8.88%$992.73M
Avoro capital advisors7.47M7.66%$857.13M
Price t rowe associates inc /md/7.11M7.29%$815.65M
Vanguard group6.27M7.18%$487.69M
T. rowe price investment management6.26M6.42%$717.52M
Blackrock4.16M5.87%$124.04M
Blackrock funding, inc. /de5.54M5.68%$635.07M
Artal group3.01M4.25%$89.72M
Bvf inc/il3.87M3.97%$444.01M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Atlas venture life science advisors2.85M37.05%$326.53M
Merck772.16K16.82%$88.54M
Bvf inc/il3.87M11.35%$444.01M
Avoro capital advisors7.47M7.70%$857.13M
Siren2.94M6.81%$336.65M
Aquilo capital management138.52K6.80%$3.79M
Aju ib investment19.65K5.36%$1.64M
Baker bros. advisors lp8.66M4.97%$992.73M
Boxer capital management429.10K3.71%$49.20M
Octagon capital advisors lp310.00K3.20%$35.55M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/7.11M0.08%1.05M
Vanguard group6.27M0.01%845.92K
T. rowe price investment management6.26M0.47%792.26K
Norges bank757.25K0.01%757.25K
Fmr12.35M0.06%649.31K

Top Sellers

HolderShares% AssetsChange
Atlas venture life science advisors2.85M37.05%-1.73M
Bvf inc/il3.87M11.35%-1.63M
Redmile group---803.29K
Deep track capital, lp---600.33K
Deerfield management company, l.p. (series c)---561.17K

New Positions

HolderShares% AssetsChangeValue
Norges bank757.25K0.01%757.25K$86.83M
Sixth street partners management company529.73K0.01%529.73K$60.74M
Clearbridge investments347.22K0.03%347.22K$39.82M
Raymond james financial135.58K0.00%135.58K$15.55M
Boone capital management113.17K3.04%113.17K$12.98M

Sold Out

HolderChange
Global financial private client-1.00
Vermillion wealth management-1.00
Dunhill financial-1.00
Financial gravity asset management-2.00
Capital performance advisors llp-3.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262889.51%97,477,1011.23%990.77%1527.80%8212.33%
Mar 31, 2026169-35.74%30,451,270-66.11%360.34%100-40.12%40-37.50%
Dec 31, 2025177-17.67%47,762,207-40.94%540.64%117-4.10%37-31.48%
Sep 30, 2025208-0.95%79,891,0442.85%991.07%117-10.00%536.00%
Jun 30, 202521518.78%78,776,9568.20%971.19%13248.31%52-7.14%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S2.95M3.55%32.79K
Fidelity Growth Compy Commingled Pl O2.24M3.46%52.60K
US Small-Cap Growth II Equity Comp2.26M2.74%310.23K
T. Rowe Price New Horizons2.26M2.74%311.10K
Fidelity Growth Company Fund2.23M2.71%47.44K
Vanguard Total Stock Mkt Idx Inv2.09M2.54%-2.72K
Vanguard Morn Total Stk Mkt Idx Investor2.09M2.54%-2.72K
Vanguard MStar Total Stk Mkt Idx Invest2.10M2.52%7.12K
Vanguard US Total Market Shares ETF1.54M2.38%1.91K
Vanguard Health Care Inv1.80M2.18%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 04, 2026Adams Brian Chief Legal OfficerSell$139.70K
Sep 04, 2026Adams Brian Chief Legal OfficerSell$251.25K
Sep 04, 2026Adams Brian Chief Legal OfficerSell$353.35K
Jul 07, 2026Mainolfi Nello Chief Executive OfficerSell$5.95M
Jun 30, 2026Jacobs Bruce N. Chief Financial OfficerSell$469.31K

Insider Transactions Trends

DateBuySell
2026 Q3-10
2026 Q2-182
2026 Q1-47
2025 Q4238
2025 Q3-2

KYMR Ownership FAQ

Who Owns Kymera Therapeutics?

Kymera Therapeutics shareholders are primarily institutional investors at 99.94%, followed by 2.12% insiders and -2.06% retail investors. The average institutional ownership in Kymera Therapeutics's industry, Biotech Stocks , is 379.01%, which Kymera Therapeutics falls below.

Who owns the most shares of Kymera Therapeutics?

Kymera Therapeutics’s largest shareholders are Fmr (12.35M shares, 12.66%), Baker bros. advisors lp (8.66M shares, 8.88%), and Avoro capital advisors (7.47M shares, 7.66%). Together, they hold 29.20% of Kymera Therapeutics’s total shares outstanding.

Does Blackrock own Kymera Therapeutics?

Yes, BlackRock owns 5.87% of Kymera Therapeutics, totaling 4.16M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.04M$. In the last quarter, BlackRock increased its holdings by 499.77K shares, a 13.67% change.

Who is Kymera Therapeutics’s biggest shareholder by percentage of total assets invested?

Atlas venture life science advisors is Kymera Therapeutics’s biggest shareholder by percentage of total assets invested, with 37.05% of its assets in 2.85M Kymera Therapeutics shares, valued at 326.53M$.

Who is the top mutual fund holder of Kymera Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Kymera Therapeutics shares, with 3.55% of its total shares outstanding invested in 2.95M Kymera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools